Revisiting Early Detection of Prostate Cancer

cited the latest EU cancer screening recommendations from 2022, 1 which provide a key step towards improving early cancer detection throughout Europe.The goal was to increase participation in breast, cervical, and colorectal cancer screening programmes in those who qualify, and extend populationbased screening programmes to lung and prostate cancer (PCa).He stressed that cancer screening is necessary to reduce socioeconomic health disparities.In light of the surge in PCa mortality worldwide, Peter Albers, Heinrich-Heine-University, Dsseldorf, Germany, continued that "smart screening is the only way".Risk-adapted, organised screening for PCa, if started early, will likely detect all relevant cancers, and with personalised riskstratified active surveillance, overtreatment can be avoided.Importantly, he added that baseline prostate-specific antigen (PSA) also works in low-income countries.